VIPROLOX

This brand name is authorized in Cyprus, Hong Kong SAR China, Malta, Singapore.

Active ingredients

The drug VIPROLOX contains one active pharmaceutical ingredient (API):

1
UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
 

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

 
Read more about Ciprofloxacin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 VIPROLOX Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01MA02 Ciprofloxacin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 52577, 53042
MT Medicines Authority MA115/00501, MA115/00502
SG Health Sciences Authority 13399P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.